Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.

MLA

Messick, Troy E., et al. “Structure-Based Design of Small-Molecule Inhibitors of EBNA1 DNA Binding Blocks Epstein-Barr Virus Latent Infection and Tumor Growth.” Science Translational Medicine, vol. 11, no. 482, Mar. 2019. EBSCOhost, https://doi.org/10.1126/scitranslmed.aau5612.

APA

Messick, T. E., Smith, G. R., Soldan, S. S., McDonnell, M. E., Deakyne, J. S., Malecka, K. A., Tolvinski, L., van den Heuvel, A. P. J., Gu, B.-W., Cassel, J. A., Tran, D. H., Wassermann, B. R., Zhang, Y., Velvadapu, V., Zartler, E. R., Busson, P., Reitz, A. B., & Lieberman, P. M. (2019). Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Science Translational Medicine, 11(482). https://doi.org/10.1126/scitranslmed.aau5612

Chicago

Messick, Troy E, Garry R Smith, Samantha S Soldan, Mark E McDonnell, Julianna S Deakyne, Kimberly A Malecka, Lois Tolvinski, et al. 2019. “Structure-Based Design of Small-Molecule Inhibitors of EBNA1 DNA Binding Blocks Epstein-Barr Virus Latent Infection and Tumor Growth.” Science Translational Medicine 11 (482). doi:10.1126/scitranslmed.aau5612.